Loading...
Setting Our Sights on Infectious Diseases.
De Rycker, Manu Horn, David Aldridge, Bree Amewu, Richard K Barry, Clifton E Buckner, Frederick S Cook, Sarah Ferguson, Michael A J Gobeau, Nathalie Herrmann, Jennifer
De Rycker, Manu
Horn, David
Aldridge, Bree
Amewu, Richard K
Barry, Clifton E
Buckner, Frederick S
Cook, Sarah
Ferguson, Michael A J
Gobeau, Nathalie
Herrmann, Jennifer
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2019-12-06
Submitted date
Files
Loading...
Open Access article
Adobe PDF, 288.81 KB
Other Titles
Abstract
In May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learnings.
Citation
ACS Infect Dis. 2019 Dec 6. doi: 10.1021/acsinfecdis.9b00371.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
2373-8227
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International